Breakthrough Blemish Care That Won't Break Your Skin Barrier

NEW YORK , Sept. 21, 2025 /PRNewswire/ -- BYOMA is raising the bar for clinical efficacy in skincare with science-backed solutions that meet unmet consumer needs. Every BYOMA product undergoes at least two independent clinical trials, with more than $2 million invested in research, over 75 trials completed, and 130,000+ skin measurements captured.

In the blemish care space, innovation has stalled. Acne affects 85% of people aged 12–24, and adult acne has risen 10% globally in the past decade, yet most treatments still rely on decades-old ingredients like Benzoyl Peroxide and Salicylic Acid. While effective, these formulas are often drying, irritating, and damaging to the skin barrier; leading to redness, peeling, and mo

See Full Page